Zimmer Biomet (NYSE: ZBH) reported Q3 earnings of $1.74 per share, meeting expectations, but shares dipped 2.3%. Revenue hit $1.82 billion, and the 2024 outlook was raised to $7.95-$8.05 per share. Watch for innovation developments amid ERP challenges.